-+ 0.00%
-+ 0.00%
-+ 0.00%

ALNYLAM PHARMACEUTICALS, INC. : CHARDAN CAPITAL MARKETS CUTS TARGET PRICE TO $375 FROM $425

Reuters·10/30/2026 05:06:49

Please log in to view news